The FDA in US authorizes commercial genetic screening for diseases

gene_screen_1024The Food and Drug Administration (FDA) has just given the thumbs-up for the DNA sequencing company 23andMe to market their Personal Genome Service Genetic Health Risk screen, which tests for markers associated with conditions including Parkinson’s, celiac, and late onset Alzheimer’s disease.

“Consumers can now have direct access to certain genetic risk information,” said director of the FDA’s Center for Devices and Radiological Health, Jeffrey Shuren.

Read the full article in Science Alert